CAMBRIDGE, Mass., April 7 /PRNewswire/ -- Codon Devices, the leader in the emerging field of Constructive Biology(TM), today announced that President and CEO John P. Danner will present the company at BIO 2006, the world’s largest biotechnology convention, to be held April 9-12, 2006 in Chicago. His presentation will be held at 9:30am on Tuesday, April 11 in McCormick Place South, Level 3, Exhibit Hall A, Room E.
Mr. Danner will present the company’s vision for a new era of Constructive Biology(TM).
About Codon Devices
Codon Devices, based in Cambridge, MA, is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices’ proprietary synthesis and design technologies improve the productivity, throughput and flexibility of its industrial, pharmaceutical and academic customers in a paradigm shift to what the company calls Constructive Biology(TM). The company’s focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy. Codon Devices’ BioFAB(TM) platform uses sophisticated informatics, robotics and sequencing technologies to accurately synthesize genetic codes orders of magnitude more rapidly and cost-effectively than other currently available technology. Codon Devices is currently scaling the platform to design and construct engineered genetic devices hundreds of kilobases to megabases in length.
Founded in 2004 within Flagship Ventures, Codon Devices commenced laboratory operations in March 2005. The company announced a Series A financing round of $13 million in June 2005 and achieved first revenues in November 2005. Investors include Alloy Ventures, Flagship Ventures, Khosla Ventures and Kleiner Perkins Caufield and Byers. Codon Devices’ scientific founders include Scientific Advisory Board Chairman George Church, Harvard Medical School; Drew Endy, Massachusetts Institute of Technology (MIT); Joseph Jacobson, MIT Media Lab; and Jay Keasling, University of California, Berkeley.
Codon Devices
CONTACT: John Danner, CEO, Codon Devices, +1-617-995-7988
